Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial
May 6 (Reuters) - Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged 50 and older, researchers rep...